Adjusting weight to reflect group differences in Model [General Sta­tis­tics]

posted by dshah  – India/United Kingdom, 2022-03-29 18:40 (48 d 02:02 ago) – Posting: # 22884
Views: 345

Dear Balakotu!
As per EMA- In parallel design studies, the treatment groups should be comparable in all known variables that may affect the pharmacokinetics of the active substance (e.g. age, body weight, sex, ethnic origin, smoking status, extensive/poor metabolic status). This is an essential pre-requisite to give validity to the results from such studies.
In general, it is recommended to have balanced between treatment arms.

Complete thread:

UA Flag
 Admin contact
22,074 posts in 4,629 threads, 1,565 registered users;
online 12 (0 registered, 12 guests [including 8 identified bots]).
Forum time: Monday 20:42 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz